NSPR - InspireMD Inc.About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $0.55 | Open | |
| Volume | 76.3K | Market Cap | 68.15M |
| Yield | Last Dividend |
| InspireMD Announces Fourth Quarter and Y... | 03/09/21 |
| Management to host investor conference call today, March 9, at 8:30am ET | |
| Coronary Stent Systems Market 2021 Estim... | 03/05/21 |
| Global Coronary Stent Systems Market Synopsis: The exclusive research report on the Global Coronary Stent Systems Market 2021-2025 examines the market... | |
| InspireMD Granted US Patent Titled 'Sten... | 03/02/21 |
| This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of ??... | |
| Insider Buying: InspireMD Inc (NYSEAMERI... | 10/22/20 |
| InspireMD Inc (NYSEAMERICAN:NSPR) Director Gary S. Roubin acquired 222,223 shares of the stock in a transaction on Friday, October 16th. The stock was... | |
| InspireMD Inc (NYSEAMERICAN:NSPR) Direct... | 10/21/20 |
| InspireMD Inc (NYSEAMERICAN:NSPR) Director Gary S. Roubin purchased 222,223 shares of the stock in a transaction that occurred on Friday, October 16th... | |
| Gary S. Roubin Buys 222,223 Shares of In... | 10/21/20 |
| InspireMD Inc (NYSEAMERICAN:NSPR) Director Gary S. Roubin purchased 222,223 shares of InspireMD stock in a transaction that occurred on Friday, Octobe... | |
| InspireMD (NYSEAMERICAN:NSPR) Stock Pric... | 10/20/20 |
| InspireMD Inc (NYSEAMERICAN:NSPR) was down 6.6% during trading on Tuesday . The stock traded as low as $0.37 and last traded at $0.39. Approximately 1... | |
| InspireMD Inc (NYSEAMERICAN:NSPR) Direct... | 10/19/20 |
| InspireMD Inc (NYSEAMERICAN:NSPR) Director Gary S. Roubin bought 222,223 shares of the stock in a transaction dated Friday, October 16th. The stock wa... | |
| InspireMD Inc (NYSEAMERICAN:NSPR) Direct... | 10/19/20 |
| InspireMD Inc (NYSEAMERICAN:NSPR) Director Gary S. Roubin bought 222,223 shares of the business???s stock in a transaction on Friday, October 16th. Th... | |
| InspireMD to Report Second Quarter 2020 ... | 07/28/20 |
| Conference Call to be held Thursday, August 5, 2020 at 8:30am ET | |
| InspireMD : Amended Statement of Ownersh... | 06/26/20 |
| INSPIREMD, INC. Filed by L1 CAPITAL GLOBAL OPPORTUNITIES MASTER FUND, LTD. FORM SC 13G/A ??? | June 26, 2020 | |
| Thinking about buying stock in Zomedica ... | 06/03/20 |
| NEW YORK, June 3, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ZOM, NSPR, GE, NCLH, and EVFM. To see how InvestorsObse... | |
| InspireMD Announces First Quarter 2020 F... | 05/12/20 |
| First quarter revenue growth driven by continued strong uptake of the CGuard??? Embolic Prevention System (EPS) in the company???s major markets ??? | |
| No surprises expected when InspireMD (NS... | 03/06/20 |
| InspireMD (NYSE: NSPR) has incurred losses consistently over the past several years. Of late, shareholders have been apprehensive about their investme... | |
| HC Wainwright Reaffirms ???Buy??? Rating... | 11/18/19 |
| InspireMD (NYSEAMERICAN:NSPR)???s stock had its ???buy??? rating reissued by equities researchers at HC Wainwright in a research report issued to clie... | |
| InspireMD (NSPR) May Report Negative Ear... | 07/29/19 |
| InspireMD (NSPR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with... | |
| InspireMD, Inc. (NSPR) CEO Jim Barry on ... | 05/14/19 |
| InspireMD, Inc. Corp. (NYSEMKT:NSPR) Q1 2019 Results Earnings Conference Call May 14, 2019, 08:00 AM ET Company Participants Jeremy Feffer - IR, LifeS... | |
| Novavax leads healthcare gainers; Geneti... | 05/14/19 |
| No summary available. | |
| InspireMD Q1 top line off 60% | 05/14/19 |
| No summary available. | |
| TME and SLDB among premarket losers | 05/14/19 |
| No summary available. | |
| InspireMD misses on revenue | 05/14/19 |
| No summary available. | |
| ARCA biopharma leads healthcare gainers;... | 05/02/19 |
| No summary available. | |
| InspireMD down 30% on pricing stock offe... | 04/04/19 |
| No summary available. | |
| InspireMD down 22% after hours on stock ... | 04/03/19 |
| InspireMD (NSPR) slumps 22% after hours in reaction to its planned public stock offering. Price, volume and terms have yet to be announced. | |
| Zynerba Pharmaceuticals and Sorrento The... | 04/03/19 |
| No summary available. | |
| Automakers, Macau Names And CinemaCon Ac... | 03/31/19 |
| No summary available. | |
| InspireMD reverse splits shares 1:50; sh... | 03/26/19 |
| No summary available. | |
| InspireMD -3% on Q4 results | 02/19/19 |
| No summary available. | |
| InspireMD reports Q4 results | 02/19/19 |
| No summary available. | |
| InspireMD's CGuard shows encouraging act... | 01/24/19 |
| No summary available. | |
| Date | 2021-03-09 (BMO) | Est. (EPS/Rev.) | ($0.08)/ 1M |
| Actual (EPS/Rev.) | $-0.10/ $158.00 K | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| FEAT. DRAKE | JOHN KROLIKOWSKI JR | 93.00 % | Follow |
| FEAT. ANDRE 3000 | JOHN KROLIKOWSKI JR | 90.00 % | Subscribe |
| FEAT. KANYE WEST | JOHN KROLIKOWSKI JR | 90.00 % | Follow |
| FEAT. PIMP C | JOHN KROLIKOWSKI JR | 90.00 % | Follow |
| FEAT. MIGUEL | JOHN KROLIKOWSKI JR | 82.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
